Fig. 3
From: Overexpression of LINC01354 predicts well prognosis and suppresses esophageal cancer progression
LINC01354’s expression correlates with patient survival. (A–F) Data from ENCORI displayed that expression of LINC01354 was associated with overall survival of cancer patients. High expression of LINC01354 in tumors led to good prognosis in BRCA (HR = 0.68, p = 0.019), ESCA (HR = 0.58, p = 0.036), KIRC (HR = 0.53, p = 6.3E-5), and UVM (HR = 0.23, p = 0.0014) patients, but poor prognosis in COAD (HR = 1.81, p = 0.0035) and STAD (HR = 1.6, p = 0.0055) patients.
